info:eu-repo/semantics/article
Synthesis and preliminary pharmacological evaluation of methoxilated indoles with possible dopaminergic central action
Fecha
2011-11Registro en:
Angel Guío, J. E.; Santiago, Ana Noemi; Rossi, Roberto Arturo; Migliore de Angel, Biagina; Barolo, Silvia Maricel; et al.; Synthesis and preliminary pharmacological evaluation of methoxilated indoles with possible dopaminergic central action; Colegio de Farmacéuticos de la Provincia de Buenos Aires; Acta Farmacéutica Bonaerense; 30; 10; 11-2011; 1934-1942
0326-2383
CONICET Digital
CONICET
Autor
Angel Guío, J. E.
Santiago, Ana Noemi
Rossi, Roberto Arturo
Migliore de Angel, Biagina
Barolo, Silvia Maricel
Andujar, Sebastian Antonio
Hernandez, Verónica
Rosales, Cecire
Charris, Jaime
Suárez-Roca, Heberto
Israel, Anita
Ramírez, María M.
Ortega, José
Herrera Cano, Natividad Carolina
Enriz, Ricardo Daniel
Resumen
Compounds 5-7were synthesized from 4-tetralones with o-iodoanilines by a radical nucleophilicsubstitution or SRN1 reaction, and were pharmacologically evaluated in order to establish their possible antago-nistic action on the central dopaminergic receptors. Behavioural parameters, such as stereotypy in rats were mea-sured after intracerebroventricular administration of these compounds at doses of 10 μg/5 μL. Our resultsdemonstrate that compounds 5-7do not affect stereotypy behaviour. However, they inhibit the apomorphine-in-duced stereotypy behaviour, suggesting the involvement of the central dopaminergic system. Also we observethat there is a concordance between the behavioural profiles induced by our compounds and those reported forclozapine 8and ziprasidone 9. It is plausible to suggest that compounds 5-7could be acting as potential atypicalantipsychotic agents. Quantum calculations performed on the basis of a comparative conformational study oftheir structures indicate a stereoelectronic similarity between the basic nuclei of compounds 4and 5-7. In addi-tion Molecular Dynamics (MD) simulations performed on compounds 5-7at the binding site of dopamine D2re-ceptor suggest that these compounds could interact with the human D2dopamine receptors.